Completed PHASE2 INTERVENTIONAL 2-arm NCT01941901

Calcium Electroporation for Treatment of Cutaneous Metastases

Sponsor: Herlev Hospital

Interventions Calcium electroporation Electrochemotherapy with bleomycin

Updated 7 times since 2017 Last updated: Nov 1, 2019 Started: Sep 30, 2013 Primary completion: Sep 30, 2016 Completion: Jan 23, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cutaneous Metastases, this trial is completed. The trial is conducted by Herlev Hospital and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Dec 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jun 2018 — Dec 2019 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

May 2018 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2017 — May 2018 [monthly]

Recruiting PHASE2

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Herlev Hospital

Data source: Herlev Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Herlev, Denmark